A Randomized Phase III Study of Anlotinib Versus Bevacizumab in Combination With CAPEOX as First-Line Therapy for Wild-Type Metastatic Colorectal Cancer: A Clinical Trial Protocol by Jinjie He MD, Yue Liu PhD, Chengcheng Liu PhD, Hanguang Hu PhD, Lifeng Sun MD, Dong Xu MD, Jun Li MD, Junye Wang MD, Xiaobing Chen MD, Rongbo Lin MD, Yi Jiang MD, Yanqiao Zhang MD, Weisheng Zhang MD, Ying Cheng MD, Xiaohong Wu MD, Mingzhi Fang MD, Enxiao Li MD, Ye Xu MD, Ye Chen MD, Jiayi Li MD, Yanyan Cui MD, Zhanyu Pan MD, Songnan Zhang MD, Ying Yuan PhD, Kefeng Ding PhD

Get full text